The Oncology Institute Announces Third Quarter 2025 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) will release its third quarter 2025 financial results after market close on Thursday, November 13, 2025.
A company conference call will follow the same day at 5:00 p.m. Eastern Time, accessible by phone or simultaneous webcast on the company Investor Relations website. A replay will be available two hours after the call through Thursday, November 20, 2025. The passcode for both the live call and replay is 13756737.
Positive
- None.
Negative
- None.
News Market Reaction – TOI
On the day this news was published, TOI gained 5.01%, reflecting a notable positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $20M to the company's valuation, bringing the market cap to $416.10M at that time.
Data tracked by StockTitan Argus on the day of publication.
CERRITOS, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that the company will release its third quarter 2025 financial results after the market close on Thursday, November 13, 2025, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13756737. The replay will be available until Thursday, November 20, 2025.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
FAQ
When will The Oncology Institute (TOI) release Q3 2025 results?
What time is The Oncology Institute (TOI) conference call for Q3 2025?
How can investors join the TOI Q3 2025 conference call by phone?
How can I access the TOI Q3 2025 webcast?
When and how can I listen to the replay of the TOI Q3 2025 call?
What is the passcode for The Oncology Institute Q3 2025 call and replay?
